Xinhuanet Co., Ltd – Trademark Portfolio
Entity Type: 16
Xinhuanet Co., Ltd holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include XINHUA, XINHUANEWS, WWW.NEWS.CN NEWS, and WWW.NEWS.CN NEWS WWW.XINHUANET.COM. The owner is based in Daxing, Beijing.
No.2 (East) Beixing Road
Tower12, 1-5th Floor
Daxing, Beijing 100031 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xinhuanet Co., Ltd's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Xinhuanet Co., Ltd have?
Xinhuanet Co., Ltd has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Xinhuanet Co., Ltd file in?
Xinhuanet Co., Ltd files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 38 (Telecommunications). Class 35 covers advertising; business management; business administration; office functions.
What are Xinhuanet Co., Ltd's most well-known trademarks?
Xinhuanet Co., Ltd's registered trademark portfolio includes well-known marks such as XINHUA, XINHUANEWS, WWW.NEWS.CN NEWS, and WWW.NEWS.CN NEWS WWW.XINHUANET.COM. These are among 4 currently registered trademarks in the portfolio.
What is Xinhuanet Co., Ltd's trademark registration success rate?
Xinhuanet Co., Ltd has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.